C. Vigneau, A. Kolko, and B. Stengel, Ten-years trends in renal replacement therapy for endstage renal disease in mainland France: Lessons from the French Renal Epidemiology and Information Network (REIN) registry, Nephrol Ther, vol.13, pp.228-235, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01897016

P. Maisonneuve, L. Agodoa, and R. Gellert, Cancer in patients on dialysis for end-stage renal disease: an international collaborative study, Lancet, vol.354, pp.93-99, 1999.

J. H. Stewart, G. Buccianti, and L. Agodoa, Cancers of the Kidney and Urinary Tract in Patients on Dialysis for End-Stage Renal Disease: Analysis of Data from the United States, Europe, and Australia and New Zealand, J Am Soc Nephrol, vol.14, pp.197-207, 2003.

J. H. Stewart, C. M. Vajdic, and L. T. Van-leeuwen, The pattern of excess cancer in dialysis and transplantation, Nephrol Dial Transplant, vol.24, pp.3225-3231, 2009.

C. Cheung, G. Chan, and S. K. Chan, Cancer Incidence and Mortality in Chronic Dialysis Population: A Multicenter Cohort Study, Am J Nephrol, vol.43, pp.153-159, 2016.

M. Y. Lin, M. C. Kuo, and C. C. Hung, Association of Dialysis with the Risks of Cancers, PLoS ONE, vol.10, issue.4, p.122856, 2015.

H. F. Lin, Y. H. Li, C. H. Wang, C. L. Chou, D. J. Kuo et al., Increased risk of cancer in chronic dialysis patients: a population-based cohort study in Taiwan, Nephrol Dial Transplant, vol.27, pp.1585-1590, 2012.

Y. C. Lee, S. Y. Hung, and H. K. Wang, Is there different risk of cancer among end-stage renal disease patients undergoing hemodialysis and peritoneal dialysis?, Cancer Medicine, 2018.

S. Vamvakas, U. Bahnerb, and A. Heidland, Cancer in End-Stage Renal Disease: Potential Factors Involved, Am J Nephrol, vol.18, pp.89-95, 1998.

G. Wong, S. Zoungas, and S. Lo, The risk of cancer in people with diabetes and chronic kidney disease, Nephrol Dial Transplant, vol.27, pp.3337-3344, 2012.

V. Donadon, M. Balbi, P. Casarin, A. Vario, and A. Alberti, Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: Potential role of insulin, World J Gastroenterol, vol.14, issue.37, pp.5695-5700, 2008.

S. S. Coughlin, E. E. Calle, L. R. Teras, J. Petrelli, and M. J. Thun, Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults, Am J Epidemiol, vol.159, pp.1160-1167, 2004.

X. Liu, K. Hemminki, A. Försti, K. Sundquist, J. Sundquist et al., Cancer risk in patients with type 2 diabetes mellitus and their relatives, Int J Cancer, vol.137, pp.903-910, 2015.

P. Vigneri, F. Frasca, L. Sciacca, G. Pandini, and R. Vigneri, Diabetes and cancer, Endocr Relat Cancer, vol.16, pp.1103-1123, 2009.

G. Shlomai, B. Neel, L. Roith, D. Gallagher, and E. J. , Type 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy, J Clin Oncol, vol.34, pp.4261-4269, 2016.

C. J. Currie, C. D. Poole, and E. Gale, The influence of glucose-lowering therapies on cancer risk in type 2 diabetes, Diabetologia, vol.52, pp.1766-1777, 2009.

A. Pladys, C. Couchoud, A. Leguillou, M. Siebert, C. Vigneau et al., Type 1 and Type 2 Diabetes and Cancer Mortality in the 2002-2009 Cohort of 39 811 French Dialyzed Patients, Plos One, vol.10, issue.5, p.125089, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01157687

L. Guillou, A. Pladys, A. Kihal, and W. , Is cancer incidence different between type 2 diabetes patients compared to nondiabetics in hemodialysis? A study from the REIN registry?, Nephrologie & Therapeutique, vol.14, pp.142-147, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01863212

, Institut national de la statistique et des études économiques (Insee). Insee Analyses, 2014.

C. Couchoud, B. Stengel, and P. Landais, The renal epidemiology and information network (REIN): new registry for endstage renal disease in France, Nephrol Dial Transplant, vol.21, p.411, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00452918

, References 1. REIN annual report, 2017.

C. Vigneau, A. Kolko, and B. Stengel, Ten-years trends in renal replacement therapy for endstage renal disease in mainland France: Lessons from the French Renal Epidemiology and Information Network (REIN) registry, Nephrol Ther, vol.13, pp.228-235, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01897016

P. Maisonneuve, L. Agodoa, and R. Gellert, Cancer in patients on dialysis for end-stage renal disease: an international collaborative study, Lancet, vol.354, pp.93-99, 1999.

J. H. Stewart, G. Buccianti, and L. Agodoa, Cancers of the Kidney and Urinary Tract in Patients on Dialysis for End-Stage Renal Disease: Analysis of Data from the United States, Europe, and Australia and New Zealand, J Am Soc Nephrol, vol.14, pp.197-207, 2003.

J. H. Stewart, C. M. Vajdic, and L. T. Van-leeuwen, The pattern of excess cancer in dialysis and transplantation, Nephrol Dial Transplant, vol.24, pp.3225-3231, 2009.

C. Cheung, G. Chan, and S. K. Chan, Cancer Incidence and Mortality in Chronic Dialysis Population: A Multicenter Cohort Study, Am J Nephrol, vol.43, pp.153-159, 2016.

M. Y. Lin, M. C. Kuo, and C. C. Hung, Association of Dialysis with the Risks of Cancers, PLoS ONE, vol.10, issue.4, p.122856, 2015.

H. F. Lin, Y. H. Li, C. H. Wang, C. L. Chou, D. J. Kuo et al., Increased risk of cancer in chronic dialysis patients: a population-based cohort study in Taiwan, Nephrol Dial Transplant, vol.27, pp.1585-1590, 2012.

Y. C. Lee, S. Y. Hung, and H. K. Wang, Is there different risk of cancer among end-stage renal disease patients undergoing hemodialysis and peritoneal dialysis?, Cancer Medicine, 2018.

S. Vamvakas, U. Bahnerb, and A. Heidland, Cancer in End-Stage Renal Disease: Potential Factors Involved, Am J Nephrol, vol.18, pp.89-95, 1998.

G. Wong, S. Zoungas, and S. Lo, The risk of cancer in people with diabetes and chronic kidney disease, Nephrol Dial Transplant, vol.27, pp.3337-3344, 2012.

V. Donadon, M. Balbi, P. Casarin, A. Vario, and A. Alberti, Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: Potential role of insulin, World J Gastroenterol, vol.14, issue.37, pp.5695-5700, 2008.

S. S. Coughlin, E. E. Calle, L. R. Teras, J. Petrelli, and M. J. Thun, Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults, Am J Epidemiol, vol.159, pp.1160-1167, 2004.

X. Liu, K. Hemminki, A. Försti, K. Sundquist, J. Sundquist et al., Cancer risk in patients with type 2 diabetes mellitus and their relatives, Int J Cancer, vol.137, pp.903-910, 2015.

P. Vigneri, F. Frasca, L. Sciacca, G. Pandini, and R. Vigneri, Diabetes and cancer, Endocr Relat Cancer, vol.16, pp.1103-1123, 2009.

G. Shlomai, B. Neel, L. Roith, D. Gallagher, and E. J. , Type 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy, J Clin Oncol, vol.34, pp.4261-4269, 2016.

C. J. Currie, C. D. Poole, and E. Gale, The influence of glucose-lowering therapies on cancer risk in type 2 diabetes, Diabetologia, vol.52, pp.1766-1777, 2009.

A. Pladys, C. Couchoud, A. Leguillou, M. Siebert, C. Vigneau et al., Type 1 and Type 2 Diabetes and Cancer Mortality in the 2002-2009 Cohort of 39 811 French Dialyzed Patients, Plos One, vol.10, issue.5, p.125089, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01157687

L. Guillou, A. Pladys, A. Kihal, and W. , Is cancer incidence different between type 2 diabetes patients compared to nondiabetics in hemodialysis? A study from the REIN registry?, Nephrologie & Therapeutique, vol.14, pp.142-147, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01863212

, Institut national de la statistique et des études économiques (Insee). Insee Analyses, 2014.

C. Couchoud, B. Stengel, and P. Landais, The renal epidemiology and information network (REIN): new registry for endstage renal disease in France, Nephrol Dial Transplant, vol.21, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00452918

O. M. Jensen, D. M. Parkin, R. Maclennan, C. S. Muir, and R. G. Skeet, Cancer Registration: Principles and Methods. Lyon: IARC, 1991.

G. Bouzillé, R. Westerlynck, and G. Defossez, Sharing Health Big Data for Research -A Design by Use Cases: The INSHARE Platform Approach, Stud Health Technol Inform, vol.245, pp.303-307, 2017.

F. Binder-foucard, A. Belot, P. Delafosse, L. Remontet, A. S. Woronoff et al., Estimation nationale de l'incidence et de la mortalité par cancer en France entre 1980 et 2012. Partie 1 -Tumeurs solides, vol.122, 2013.

A. M. Butler, A. F. Olshan, and A. V. Kshirsagar, Cancer Incidence Among US Medicare ESRD Patients Receiving Hemodialysis, vol.65, pp.763-72, 1996.

C. C. Chien, M. M. Han, and Y. H. Chiu, Epidemiology of cancer in end-stage renal disease dialysis patients: a national cohort study in Taiwan, J Cancer, vol.8, issue.1, pp.9-18, 2017.

J. S. Kasper and E. Giovannucci, A Meta-analysis of Diabetes Mellitus and the Risk of Prostate Cancer, Cancer Epidemiol Biomarkers Prev, vol.15, issue.11, pp.2056-2062, 2006.

G. Libby, L. A. Donnelly, P. T. Donnan, D. R. Alessi, A. D. Morris et al., New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes, Diabetes Care, vol.32, issue.9, pp.1620-1625, 2009.

K. Hosono, H. Endo, and H. Takahashi, Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial, Cancer Prev Res (Phila), vol.3, issue.9, pp.1077-1083, 2010.

. Kdigo, Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International Supplements, vol.3, pp.1-163, 2012.

V. Donadon, M. Balb, P. Casarin, A. Vario, and A. Alberti, Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: Potential role of insulin, World J Gastroenterol, vol.14, issue.37, pp.5695-5700, 2008.

S. S. Coughlin, E. E. Calle, L. R. Teras, J. Petrelli, J. Thun et al., Diabetes Mellitus as a Predictor of Cancer Mortality in a Large Cohort of US Adults, Am J of Epidemiol, vol.159, pp.1160-1167, 2004.

C. M. Rhee, A. M. Leung, C. P. Kovesdy, K. E. Lynch, G. A. Brent et al., Updates on the management of diabetes in dialysis patients, Semin Dial, vol.27, issue.2, pp.135-180, 2014.

H. Autorité-de-santé, Guide du parcours de soins -Maladie Rénale Chronique de l'adulte, HAS, 2012.

T. Datzmann, S. Fuchs, A. D. Hohensteinc, B. Schmitte, J. Schindler et al., Systematic review and meta-analysis of randomised controlled clinical trial evidence refutes relationship between pharmacotherapy with angiotensin receptor blockers and an increased risk of cancer, European Journal of Internal Medicine, 2019.

,

C. C. Huang, W. L. Chan, and Y. C. Chen, Angiotensin II receptor blockers and risk of cancer in patients with systemic hypertension, Am J Cardiol, vol.107, issue.7, pp.1028-1061, 2011.

C. H. Chang, J. W. Lin, L. C. Wu, and M. S. Lai, Angiotensin receptor blockade and risk of cancer in type 2 diabetes mellitus: a nationwide case-control study, J Clin Oncol, vol.29, issue.22, pp.3001-3008, 2011.

G. Verhoest, T. Dolley-hitze, and F. Jouan, Sunitinib Combined with Angiotensin-2 Type-1
URL : https://hal.archives-ouvertes.fr/hal-01063976

, Receptor Antagonists Induces More Necrosis: A Murine Xenograft Model of Renal Cell Carcinoma, BioMed Research International, 2014.

P. Tuppin, J. Rudant, P. Constantinou, and C. Gastaldi-ménager, Value of a National Administrative Database to Guide Public Decisions: From the Système National d'information Interrégimes de l'Assurance Maladie (SNIIRAM) to the Système National Des Données de Santé (SNDS) in France, Revue D'Epidemiologie Et De Sante Publique, vol.65, issue.4, pp.149-67, 2017.